Gesundheit, Arzneimittel, Wohlfahrtsökonomik, Extra-Welfarismus. - Since 1961 access to market for innovative pharmaceuticals was increasingly regulated. The first step was a simple registration procedure, followed by federal licensing in 1978. Since 1989 the licensing was complemented by price...

Independently of their size, enterprises have to deal with the increasing complexity of environmental factors and dynamics, for instance, demographic change. The focus of interest in this investigation concentrates on the relevance of diversity management for SMEs (small and middle-sized...